{
    "clinical_study": {
        "@rank": "15071", 
        "arm_group": {
            "arm_group_label": "Cardiac patients receiving PET/MR", 
            "arm_group_type": "Other", 
            "description": "PET-MRI with intravenous Gadolinium and FDG. The entire study will take approximately one hour."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to understand how simultaneous PET/MR acquisition can provide\n      novel qualitative and quantitative biomarkers to guide clinical intervention and predict\n      prognosis of patients with cardiovascular disease."
        }, 
        "brief_title": "Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Cardiac Disease", 
        "condition_browse": {
            "mesh_term": "Heart Diseases"
        }, 
        "detailed_description": {
            "textblock": "-  To compare regional myocardial uptake of FDG on images obtained on a standard PET\n           camera with the new PET/MR camera, in patients with coronary artery disease.\n\n        -  To compare viability maps obtained with cardiac MR images and FDG-PET for delineation\n           of myocardial infarct core and border zone, in patients with coronary artery disease.\n\n        -  To correlate MRI myocardial strain with relative myocardial FDG uptake in patients with\n           a previous myocardial infarction.\n\n        -  To interrogate if simultaneous acquisition of cardiac PET and viability cardiac MR\n           differ from acquisitions obtained independently, with special focus on attenuation\n           correction methods\n\n        -  To combined MRI scar map with FDG-PET uptake in patients with cardiac sarcoidosis and\n           myocarditis.\n\n        -  To correlate morphologic characteristics of atherosclerotic disease in the thoracic and\n           abdominal aorta with FDG uptake and ferumoxytol enhancement, as a marker of\n           inflammation.\n\n        -  To evaluate cardiac strain and myocardial scar burden in obese patients with and\n           without diabetes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with ischemic and non-ischemic cardiac disease referred for cardiac PET for\n             viability imaging.\n\n        Exclusion Criteria:\n\n          -  Contraindications for MRI, including cardiac pacemaker, claustrophobia, retained\n             metallic foreign body, cochlear implant, Aneurysm clip in the brain, pregnancy and\n             eGFR less than 45%."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062008", 
            "org_study_id": "Combined PET-MRI"
        }, 
        "intervention": {
            "arm_group_label": "Cardiac patients receiving PET/MR", 
            "description": "PET-MRI with intravenous Gadolinium and FDG. The entire study will take approximately one hour.", 
            "intervention_name": "PET-MRI", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Positron Emission Tomography-Magnetic Resonance Imaging", 
            "Cardiac Disease"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "contact": {
                "email": "Karen.Ordovas@ucsf.edu", 
                "last_name": "Karen G Ordovas, MD,MAS", 
                "phone": "415-476-1397"
            }, 
            "contact_backup": {
                "email": "Miguel.Pampaloni@ucsf.edu", 
                "last_name": "Miguel Pampaloni, MD"
            }, 
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94107"
                }, 
                "name": "UCSF University of California in San Francisco"
            }, 
            "investigator": {
                "last_name": "Karen G Ordovas, MD, MAS", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications", 
        "overall_official": {
            "affiliation": "Assistent Professor", 
            "last_name": "Karen G Ordovas, MD,MAS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlation of combined PET/MR findings with independently acquired PET and MR data", 
            "measure": "FDG uptake in SUVs (Standardized Uptake Values)", 
            "safety_issue": "No", 
            "time_frame": "2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062008"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}